The post DAT Inflows Sink to Lowest Level Since October 2024 appeared on BitcoinEthereumNews.com. Monthly inflows into digital asset treasury (DAT) companies haveThe post DAT Inflows Sink to Lowest Level Since October 2024 appeared on BitcoinEthereumNews.com. Monthly inflows into digital asset treasury (DAT) companies have

DAT Inflows Sink to Lowest Level Since October 2024

For feedback or concerns regarding this content, please contact us at [email protected]

Monthly inflows into digital asset treasury (DAT) companies have slowed to about $555 million, the lowest levels since October 2024, the month before the 2024 US election pump, according to data from DefiLlama.

Inflows into digital asset treasury companies slipped to about $32.4 million ahead of the election, then rebounded to more than $12.3 billion following the results of the 2024 elections in the United States and a pro-crypto regulatory shift, DefiLlama’s data shows.

Treasury inflows contracted in 2025 and remained well below $10 billion in monthly inflows until August 2025, before sharply falling again.

Monthly inflows into digital asset treasury companies. Source: DefiLlama

Digital asset treasury companies have faced a challenging business environment over the last year, which was made worse by the crypto market crash in October that kicked off a multi-month bear market and rolled back crypto prices to pre-election levels.

Related: Crypto treasury companies likely to consolidate in 2026: Crypto exec

Treasury companies face reinvention following market crash

Treasury companies must evolve their business strategies or risk stagnating, according to Patrick Ngan, chief investment officer of Zeta Network Group, a technology company.

“Corporate Bitcoin treasuries now need to show they can actually use the asset, not just warehouse it,” Ngan said.

Crypto treasury companies with an operating business that produces cash flow will outperform those that simply accumulate and hold crypto, he said.

The 10 biggest crypto treasury companies, ranked by their crypto holdings. Source: DefiLlama

Treasury companies can generate revenue by staking or providing validation services to secure proof-of-stake blockchain networks, mining proof-of-work cryptocurrencies, lending in the decentralized finance (DeFi) space, and other unrelated businesses.

Real estate investor Grant Cardone last year expanded his multifamily housing fund strategy by combining real estate and Bitcoin (BTC) into hybrid digital asset treasury investment vehicles.

The fund benefits from the appreciation of the physical property, real estate tax advantages and rental income that can be funneled into additional BTC purchases, Cardone told Cointelegraph.

“If the company’s just bitcoin, why am I investing in that company? Real estate is the best treasury company you can build because it’s not a product that is discretionary — you have to buy housing,” he said.

Magazine: Big questions: Should you sell your Bitcoin for nickels for a 43% profit?

Cointelegraph is committed to independent, transparent journalism. This news article is produced in accordance with Cointelegraph’s Editorial Policy and aims to provide accurate and timely information. Readers are encouraged to verify information independently. Read our Editorial Policy https://cointelegraph.com/editorial-policy

Source: https://cointelegraph.com/news/crypto-treasury-inflow-slow-october-2024?utm_source=rss_feed&utm_medium=feed&utm_campaign=rss_partner_inbound

Market Opportunity
Bitcoin Logo
Bitcoin Price(BTC)
$68,006.15
$68,006.15$68,006.15
-0.72%
USD
Bitcoin (BTC) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Key Takeaways Vitalik Buterin wants Ethereum apps built to survive without developers, corporate servers, or trusted third parties Two major […] The post Vitalik
Share
Coindoo2026/03/07 15:49
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

The post Short-term profit-taking pushes Bitcoin back below key $70K level – What next? appeared on BitcoinEthereumNews.com. Bitcoin [BTC] rallied as high as $74
Share
BitcoinEthereumNews2026/03/07 16:09